Your browser doesn't support javascript.
loading
Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
Takeshita, Masaru; Nishina, Naoshi; Moriyama, Saya; Takahashi, Yoshimasa; Uwamino, Yoshifumi; Nagata, Mika; Aoki, Wataru; Masaki, Katsunori; Ishii, Makoto; Saya, Hideyuki; Kondo, Yasushi; Kaneko, Yuko; Suzuki, Katsuya; Fukunaga, Koichi; Takeuchi, Tsutomu.
Afiliação
  • Takeshita M; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan. Electronic address: takeshita@a5.keio.jp.
  • Nishina N; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Moriyama S; Department of Immunology, National Institute of Infectious Diseases, Tokyo, 160-8582, Japan.
  • Takahashi Y; Department of Immunology, National Institute of Infectious Diseases, Tokyo, 160-8582, Japan.
  • Uwamino Y; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Nagata M; Clinical Laboratory, Keio University Hospital, Tokyo, 160-8582, Japan.
  • Aoki W; Clinical Laboratory, Keio University Hospital, Tokyo, 160-8582, Japan.
  • Masaki K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Ishii M; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Kondo Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Kaneko Y; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Suzuki K; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Fukunaga K; Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
  • Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, 160-8582, Japan.
Virology ; 555: 35-43, 2021 03.
Article em En | MEDLINE | ID: mdl-33450669
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Proteínas do Nucleocapsídeo de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Virology Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Proteínas do Nucleocapsídeo de Coronavírus / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Virology Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos